Four phase 1 trials to evaluate the safety and pharmacokinetic profile of single and repeated dosing of SCO‐101 in adult male and female volunteers
2020 ◽
Vol 127
(4)
◽
pp. 329-337
◽
Keyword(s):
Phase 1
◽